ENDOCEUTICS
Endodontics has the expertise to carry out clinical development and the recording and marketing of its products. Endoceutics benefits from a portfolio of products at different stages of development. Endodontics has a mission to provide a better quality of life to women
ENDOCEUTICS
Social Links:
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
2006-01-01
Address:
Mont-saint-hilaire, Quebec, Canada
Country:
Canada
Website Url:
http://www.endoceutics.com
Total Employee:
101+
Status:
Active
Contact:
+1 418 653 0033
Total Funding:
85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving Microsoft Azure Blob Storage Videotron
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Investors List
CRG
CRG investment in Debt Financing - Endoceutics
Official Site Inspections
http://www.endoceutics.com Semrush global rank: 5.92 M Semrush visits lastest month: 1.39 K
- Host name: 40.69.106.97
- IP address: 40.69.106.97
- Location: Québec Canada
- Latitude: 46.7949
- Longitude: -71.247
- Timezone: America/Toronto
- Postal: G1S
More informations about "Endoceutics"
About us - Endoceutics
Endoceutics is a private pharmaceutical company operating in the fields of women’s health and hormone-sensitive cancer prevention and treatment. Endoceutics is actively committed to advancing basic sciences, clinical …See details»
Endoceutics - Crunchbase Company Profile & Funding
Endoceutics closed its last funding round on Jan 11, 2017 from a Debt Financing round. Who are Endoceutics 's competitors? Alternatives and possible competitors to Endoceutics may include Aura Biosciences , Arrowhead …See details»
Management team - Endoceutics
© Endoceutics, Inc. 2024. All rights reserved. Endoceutics and Intrarosa are trademarks of Endoceutics, Inc. SigmundSee details»
Endoceutics Company Profile 2024: Valuation, Investors
Endoceutics was founded in 2006. Where is Endoceutics headquartered? Endoceutics is headquartered in Quebec City, Canada. What is the size of Endoceutics? Endoceutics has 95 …See details»
Endoceutics, Inc. Company Profile - Dun & Bradstreet
Company Description: Ending breast cancer is top priority at EndoCeutics. The trial-phase biopharmaceutical company develops hormone therapies for treating and preventing breast …See details»
Endoceutics, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
More research is needed on elastic fiber production, organization, and integration with other cutaneous extracellular matrix proteins, and how they may be affected by sex steroid …See details»
Endoceutics - Overview, News & Similar companies - ZoomInfo
Endoceutics, Inc. is focused on women's health. Endoceutics also manufactures its innovative INTRAROSA as well as other drugs on behalf of its part ners and customers. Endoceutics has …See details»
ENDOCEUTICS, INC. ANNOUNCES INITIATION OF THE SALE AND …
1 ENDOCEUTICS, INC. ANNOUNCES INITIATION OF THE SALE AND INVESTMENT SOLICITATION PROCESS Québec, Canada: – January 4, 2023: On September 26, 2022, …See details»
Endoceutics Company Profile - Office Locations, Competitors
Endoceutics Summary. Company Summary. Overview. Endoceutics is a pharmaceutical company. It offers hormonal treatments for menopause, breast cancer, endometrial, prostate …See details»
Interview: Fernand Labrie – President and CEO, Endoceutics
Sep 10, 2017 Dr. Fernand Labrie shares the significant achievements of Endoceutics, in launching its first breakthrough product for post-menopausal vulvar and vaginal atrophy, …See details»
Cosette Pharmaceuticals Acquires Intrarosa® from Endoceutics, Inc.
June 13, 2023 – Cosette Pharmaceuticals, Inc. (“Cosette”), a US-based specialty pharmaceutical company with a focus on women’s health and cardiovascular medicines, has completed the …See details»
Cosette Pharmaceuticals Acquires Intrarosa - Business Wire
Jun 8, 2023 Cosette Pharmaceuticals Acquires Intrarosa ® from Endoceutics, Inc. Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent …See details»
Endoceutics® Receives Health Canada Approval for INTRAROSA® …
Nov 6, 2019 Endoceutics also has the expertise for clinical development, registration and commercialization of its products. ... Organization Profile. ENDOCEUTICS. Contact Cision. …See details»
Lupin Pharma Canada Announces Partnership with Endoceutics for …
Mar 9, 2021 Endoceutics, Inc. is focused on women’s health and possesses manufacturing plants and equipment to manufacture drugs. Endoceutics has the expertise for clinical …See details»
ENDOCEUTICS ANNOUNCES ACQUISITION OF THE INTRAROSA® …
May 27, 2020 Endoceutics, Inc. is focused on women’s health and possesses manufacturing plants and to equipment manufacture drugs, as well as bioanalytical laboratories. Endoceutics …See details»
Endoceutics close to marketing deal with U.S. pharma partner for …
Nov 29, 2016 Endoceutics should have a U.S. distribution partner for Intrarosa, a newly FDA-approved treatment for vulvovaginal atrophy in postmenopausal women, before the end of the …See details»
Accueil - Endoceutics
ENDOCEUTICS OEUVRE DANS LE DOMAINE DE LA SANTÉ DES FEMMES ainsi que la prévention et le traitement des cancers hormono-sensibles. Notre objectif en tant qu'entreprise …See details»
Endoceutics obtains CCAA protection, approval of sale transactions
On September 26, 2022, Endoceutics has commenced proceedings in obtaining protection under the Companies' Creditors Arrangement Act (the “CCAA”) quickly, allowing Endoceutics to …See details»
News - Endoceutics
Mar 8, 2021 Endoceutics, Université Laval, and CHU de Québec settle their disputes March 27, 2019. Québec City, Canada, March 27, 2019 – Endoceutics Inc., Université Laval, and CHU …See details»